| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |